Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations-Reference-Cited by-同舟云学术

Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations

Published:2018-09-05 Issue:11 Volume:35 Page:
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Pandey Shweta,Kumar Vijay,Leekha Ankita,Rai Nishant,Ahmad Farhan Jalees,Verma Anita Kamra,Talegaonkar Sushama

Funder

Indian Council of Medical Research

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/article/10.1007/s11095-018-2478-2/fulltext.html

Reference57 articles.

1. Pandey S, Rai N, Rawat P, Ahmad FJ, Talegaonkar S. Nanofacilitated synergistic treatment for rheumatoid arthritis: a ‘three pronged’ approach. Med Hypotheses. 2016;92:44–7.

2. Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 2012;18:S295–302.

3. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4:265–72.

4. Pandey S, Mahtab A, Rai N, Rawat P, Ahmad FJ, Talegaonkar S. Emerging role of CD44 receptor as a potential target in disease diagnosis: a patent review. Recent Patents Inflamm Allergy Drug Discov. 2017;11(2):77–91.

5. Kalinoglou AS, Deli C, Kitas GD, Jamurtas AZ. Muscle wasting in rheumatoid arthritis: the role of oxidative stress. World J Rheumatol. 2014;4(3):44–53.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ionic liquid-based Ionogel: A novel strategy to improve dermal delivery and in vivo efficacy of etodolac in rheumatoid arthritis management;Journal of Molecular Liquids;2024-10

2. Recent innovations in topical delivery for management of rheumatoid arthritis: A focus on combination drug delivery;Drug Discovery Today;2024-08

3. Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges;Journal of Nanobiotechnology;2024-07-22

4. Dual drug nanoparticle synergistically induced apoptosis, suppressed inflammation, and protected autophagic response in rheumatoid arthritis fibroblast-like synoviocytes;Immunology Letters;2024-06

5. Is it advantageous to use quality by design (QbD) to develop nanoparticle-based dosage forms for parenteral drug administration?;International Journal of Pharmaceutics;2024-05